Incidence of Supraventricular Arrhythmias during Autologous peripheral blood stem cell transplantation

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 8, 2013, Pages 1233-1237

  Singla, Abhishek ^a   Hogan, William J ^b   Ansell, Stephen M ^b   Buadi, Francis K ^b   Dingli, David ^b   Dispenzieri, Angela ^b   Gastineau, Dennis A ^b   Gertz, Morie A ^b   Hayman, Suzanne R ^b   Inwards, David J ^b   Johnston, Patrick B ^b   Lacy, Martha Q ^b   Litzow, Mark R ^b   Micallef, Ivana N ^b   Porrata, Luis F ^b   Kumar, Shaji K ^b  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Antiarrhythmics; Arrhythmia; Atrial fibrillation; Autologous hematopoietic cell transplant (AHCT); Electrocardiogram (ECG)

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT;

ADULT; AGE; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CARDIOVASCULAR RISK; CARDIOVERSION; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; SUPRAVENTRICULAR TACHYCARDIA;

ANTIARRHYTHMICS; ARRHYTHMIA; ATRIAL FIBRILLATION; AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANT (AHCT); ELECTROCARDIOGRAM (ECG);

ADULT; AGED; ARRHYTHMIAS, CARDIAC; ATRIAL FIBRILLATION; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TACHYCARDIA, SUPRAVENTRICULAR; YOUNG ADULT;

EID: 84880405741     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.05.019     Document Type: Article

References (26)

1. Gratwohl A., Baldomero H., Aljurf M., et al. Hematopoietic stem cell transplantation: a global perspective. JAMA 2010, 303:1617-1624.
2. Jones J.A., Qazilbash M.H., Shih Y.C., et al. In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies: clinical and economic outcomes from the Nationwide Inpatient Sample. Cancer 2008, 112:1096-1105.
3. Afessa B., Abdulai R.M., Kremers W.K., et al. Risk factors and outcome of pulmonary complications after autologous hematopoietic stem cell transplant hematopoietic stem cell transplant complications. CHEST J 2012, 141:442-450.
4. Gertz M.A., Gastineau D.A., Lacy M.Q., et al. SCT without growth factor in multiple myeloma: engraftment kinetics, bacteremia and hospitalization. Bone Marrow Transplant 2011, 46:956-961.
5. Murdych T., Weisdorf D.J. Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997. Bone Marrow Transplant 2001, 28:283-287.
6. Hidalgo J.D., Krone R., Rich M.W., et al. Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes. Bone Marrow Transplant 2004, 34:615-619.
7. Fatema K., Gertz M.A., Barnes M.E., et al. Acute weight gain and diastolic dysfunction as a potent risk complex for post stem cell transplant atrial fibrillation. Am J Hematol 2009, 84:499.
8. Peres E., Levine J.E., Khaled Y.A., et al. Cardiac complications in patients undergoing a reduced-intensity conditioning hematopoietic stem cell transplantation. Bone Marrow Transplant 2010, 45:149-152.
9. Feliz V., Saiyad S., Ramarao S.M., et al. Melphalan-induced supraventricular tachycardia: incidence and risk factors. Clin Cardiol 2011, 34:356-359.
10. Olivieri A., Corvatta L., Montanari M., et al. Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells. Bone Marrow Transplant 1998, 21:1049.
11. Gertz M.A., Ansell S.M., Dingli D., et al. Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative. Mayo Clin Proc 2008, 83:1131-1138.
12. Fuster V., Ryden L.E., Cannom D.S., et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. JAm Coll Cardiol 2011, 57:e101-e198.
13. 2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma. Bone Marrow Transplant 1999, 23:1003.
14. Sirohi B., Powles R., Treleaven J., et al. The role of autologous transplantation in patients with multiple myeloma aged 65 years and over. Bone Marrow Transplant 2000, 25:533.
15. Phillips G.L., Meisenberg B., Reece D.E., et al. Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I study. Biol Blood Marrow Transplant 2004, 10:473-483.
16. Rahman J.E., Helou E.F., Gelzer-Bell R., et al. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. JAm Coll Cardiol 2004, 43:410-415.
17. Selvanayagam J.B., Hawkins P.N., Paul B., et al. Evaluation and management of the cardiac amyloidosis. JAm Coll Cardiol 2007, 50:2101-2110.
18. Banypersad S.M., Moon J.C., Whelan C., et al. Updates in cardiac amyloidosis: a review. JAm Heart Assoc 2012.
19. Chong B.H., Pong V., Lam K.F., et al. Frequent premature atrial complexes predict new occurrence of atrial fibrillation and adverse cardiovascular events. Europace 2012, 14:942-947.
20. Perez M.V., Dewey F.E., Marcus R., et al. Electrocardiographic predictors of atrial fibrillation. Am Heart J 2009, 158:622.
21. Cheng S., Keyes M.J., Larson M.G., et al. Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA 2009, 301:2571-2577.
22. Dilaveris P.E., Gialafos E.J., Sideris S.K., et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998, 135:733-738.
23. Agarwal Y.K., Aronow W.S., Levy J.A., Spodick D.H. Association of interatrial block with development of atrial fibrillation. Am J Cardiol 2003, 91:882.
24. Reisinger J., Dubrey S.W., Lavalley M., et al. Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement. JAm Coll Cardiol 1997, 30:1046-1051.
25. Murtagh B., Hammill S.C., Gertz M.A., et al. Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol 2005, 95:535-537.
26. Dubrey S., Hawkins P., Falk R. Amyloid diseases of the heart: assessment, diagnosis, and referral. Heart 2011, 97:75-84.